Title : Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling.

Pub. Date : 2020 May 15

PMID : 32587778






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Upregulation of CD105 was abrogated by anlotinib, which targets multiple receptor tyrosine kinases including VEGFR2/3, FGFR1-4, PDGFRalpha/beta, C-Kit, and RET. anlotinib kinase insert domain receptor Homo sapiens